About Aurie
Aurie is a company based in New York (United States) founded in 2017 by Marjorie Nelson, Daniel Wollin, and Souvik Paul. Aurie has raised $12.23 million across 2 funding rounds from investors including Lakehouse Ventures. The company has 4 employees as of December 31, 2022. Aurie offers products and services including Reusable Catheter System. Aurie operates in a competitive market with competitors including Camstent, NanoVibronix, BioDerm, ProvenMed and FLUME, among others.
- Headquarter New York, United States
- Employees 4 as on 31 Dec, 2022
- Founders Marjorie Nelson, Daniel Wollin, Souvik Paul
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$12.23 M (USD)
in 2 rounds
-
Latest Funding Round
$6 M (USD), Series A
Apr 04, 2024
- Investors
-
Employee Count
4
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aurie
Aurie offers a comprehensive portfolio of products and services, including Reusable Catheter System.
No-touch system for safe, hygienic catheterization to support independence and health.
People of Aurie
Unlock access to complete
Unlock access to complete
Funding Insights of Aurie
Aurie has successfully raised a total of $12.23M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aurie
Aurie has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Lakehouse Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A pre-seed venture capital firm is operated for innovative founders.
|
Locked | Locked | Locked |
Investor details for Aurie
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aurie
Investment portfolio details for Aurie
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aurie
Detailed financials for Aurie
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aurie Comparisons
Peer comparison for Aurie
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aurie
Aurie operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Camstent, NanoVibronix, BioDerm, ProvenMed and FLUME, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Polymer coating for medical devices
|
|
| Locked | Locked | Locked |
Provider of ultrasound therapy devices for multiple health purposes
|
|
| Locked | Locked | Locked |
Hydrocolloid products are developed for urinary management and skin protection.
|
|
| Locked | Locked | Locked |
Devices for urinary incontinence treatment are provided by ProvenMed.
|
|
| Locked | Locked | Locked |
Developer of a catheter for the treatment of urinary incontinence
|
Detailed competitors of Aurie
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aurie
Complete news archive for Aurie
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aurie
Aurie was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Aurie is headquartered in New York, United States. It is registered at New York, New York, United States.
Souvik Paul is the current CEO of Aurie. They have also founded this company.
Aurie is a funded company, having raised a total of $12.23M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Aurie is 4.
Aurie was established in 2017 in New York, United States, within the medical device sector. Focus is placed on the creation of a reusable intermittent urinary catheter system. This technology is designed for rehabilitation among spinal cord injury patients and management of urinary retention conditions. Operations involve engineering an automated self-catheter solution to support user independence in daily care routines.
Aurie's top competitors include NanoVibronix, Camstent and BioDerm.
Aurie offers Reusable Catheter System.
Aurie has 1 investor. Key investors include Lakehouse Ventures.